Germline TP53 mutations and Li-Fraumeni syndrome

被引:291
作者
Varley, JM [1 ]
机构
[1] Christie NHS Trust, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England
关键词
germline; p53; TP53; cancer; tumor; Li-Fraumeni syndrome; LFS; LFL; germline mutation; adrenocortical carcinoma; ACC; mutation detection;
D O I
10.1002/humu.10185
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
There are now reports of nearly 250 independent germline TP53 (p53) mutations in over 100 publications. Such mutations are typically associated with Li-Fraumeni or Li-Fraumeni-like syndrome, although many have been identified in cohorts of patients with tumors considered to be typical of LFS. In general, the spectrum of mutations that has been detected in the germline reflects that found in tumors, although there are some notable exceptions in certain tumor types. Detailed knowledge of the pedigrees allows a comprehensive analysis of genotype-phenotype correlations and an understanding of the tumors that are associated with germline TP53 mutations. This review will discuss the spectrum of mutations and the methods for mutation detection, the tumors associated with inheritance of a germline mutation, and some of the ethical and clinical problems in patients with a germline TP53 mutation.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 74 条
[1]   Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome [J].
Bell, DW ;
Varley, JM ;
Szydlo, TE ;
Kang, DH ;
Wahrer, DCR ;
Shannon, KE ;
Lubratovich, M ;
Verselis, SJ ;
Isselbacher, KJ ;
Fraumeni, JF ;
Birch, JM ;
Li, FP ;
Garber, JE ;
Haber, DA .
SCIENCE, 1999, 286 (5449) :2528-2531
[2]   The UMD-p53 database:: New mutations and analysis tools [J].
Béroud, C ;
Soussi, T .
HUMAN MUTATION, 2003, 21 (03) :176-181
[3]   Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome [J].
Birch, JM ;
Blair, V ;
Kelsey, AM ;
Evans, DG ;
Harris, M ;
Tricker, KJ ;
Varley, JM .
ONCOGENE, 1998, 17 (09) :1061-1068
[4]   LINKAGE STUDIES IN A LI-FRAUMENI FAMILY WITH INCREASED EXPRESSION OF P53 PROTEIN BUT NO GERMLINE MUTATION IN P53 [J].
BIRCH, JM ;
HEIGHWAY, J ;
TEARE, MD ;
KELSEY, AM ;
HARTLEY, AL ;
TRICKER, KJ ;
CROWTHER, D ;
LANE, DP ;
SANTIBANEZKOREF, MF .
BRITISH JOURNAL OF CANCER, 1994, 70 (06) :1176-1181
[5]  
BIRCH JM, 1994, CANCER RES, V54, P1298
[6]   Relative frequency and morphology of cancers in carriers of germline TP53 mutations [J].
Birch, JM ;
Alston, RD ;
McNally, RJQ ;
Evans, DGR ;
Kelsey, AM ;
Harris, M ;
Eden, OB ;
Varley, JM .
ONCOGENE, 2001, 20 (34) :4621-4628
[7]   EXCESS RISK OF BREAST-CANCER IN THE MOTHERS OF CHILDREN WITH SOFT-TISSUE SARCOMAS [J].
BIRCH, JM ;
HARTLEY, AL ;
MARSDEN, HB ;
HARRIS, M ;
SWINDELL, R .
BRITISH JOURNAL OF CANCER, 1984, 49 (03) :325-331
[8]  
BIRCH JM, 1990, CANCER, V66, P2237
[9]  
BORRESEN AL, 1992, CANCER RES, V52, P3234
[10]   Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome [J].
Bougeard, G ;
Limacher, JM ;
Martin, C ;
Charbonnier, F ;
Killian, A ;
Delattre, O ;
Longy, M ;
Jonveaux, P ;
Fricker, JP ;
Stoppa-Lyonnet, D ;
Flaman, JM ;
Frébourg, T .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (04) :253-256